These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27432118)

  • 1. Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.
    Li X; Guo J; Ding AP; Qi WW; Zhang PH; Lv J; Qiu WS; Sun ZQ
    Technol Cancer Res Treat; 2017 Aug; 16(4):428-434. PubMed ID: 27432118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
    Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Curran WJ; Landry JC; Maithel SK; Yu DS
    Cancer; 2013 Sep; 119(17):3148-55. PubMed ID: 23720157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer.
    Ruan J; Mei L; Zhu Q; Shi G; Wang H
    Int J Clin Exp Pathol; 2015; 8(11):15035-8. PubMed ID: 26823841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
    Lu L; Zhai X; Yuan R
    Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.
    de Oca J; Azuara D; Sanchez-Santos R; Navarro M; Capella G; Moreno V; Sola A; Hotter G; Biondo S; Osorio A; Martí-Ragué J; Rafecas A
    Int J Colorectal Dis; 2008 Jan; 23(1):21-7. PubMed ID: 17805550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients.
    He L; Peng K; Liu Y; Xiong J; Zhu FF
    Onco Targets Ther; 2013; 6():1539-43. PubMed ID: 24204164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection.
    Li ZM; Peng YF; Du CZ; Gu J
    Colorectal Dis; 2016 Mar; 18(3):255-63. PubMed ID: 26400111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
    Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
    Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer.
    Lopez-Guerra JL; Verdugo-Sivianes EM; Otero-Albiol D; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Marin JJ; Carnero A
    Oncotarget; 2015 Oct; 6(30):30343-56. PubMed ID: 26327509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.
    Sánchez-Velázquez P; Pera M; Jiménez-Toscano M; Mayol X; Rogés X; Lorente L; Iglesias M; Gallén M
    Clin Transl Oncol; 2018 Oct; 20(10):1321-1328. PubMed ID: 29623587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
    Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
    J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
    Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
    PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
    Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.